Envestnet Asset Management Inc Oncternal Therapeutics, Inc. Transaction History

Envestnet Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.83 - $17.8 $913 - $19,580	-1,100 Reduced 2.0%	53,911 $48,000
Q2 2022 Aug 03, 2022	BUY	$0.7 - $1.56 $3,451 - $7,690	4,930 Added 9.84%	55,011 $61,000
Q3 2021 Oct 07, 2021	SELL	$3.37 - $4.76 $168,500 - $238,000	-50,000 Reduced 49.96%	50,081 $209,000
Q1 2021 May 04, 2021	BUY	$4.59 - $9.04 $459,371 - $904,732	100,081 New	100,081 $833,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.